Dr. Robert DeCresce is the Chief Advisor, Pathology & Lab Diagnostics at Scale Physician Group.
– Nearly 30 years experience as a Pathologist at University Pathologists, PC.
– Former Vice President of MetPath, Inc. (now Quest Diagnostics).
– Operating Partner at Shore Capital Partners.
Dr. DeCresce has served as Director of Clinical Laboratories at Rush University Medical Center since 1991 and currently serves as Chairman of the Department of Pathology at Rush Medical College in Chicago.
Dr. DeCresce has served on the boards of numerous healthcare, diagnostic & laboratory companies and organizations, including:
PathLab Inc. (Madison Dearborn)
Solstas Clinical Labs (Welsh Carson)
Pacific Diagnostic Laboratories
VWR International, Inc. (Madison Dearborn / Public)
Strata Path Dx (Linden)
ClearPath Diagnostics (Shore)
Bright View (Shore)
Rush University Medical Center Trustee
From 1983 till 1987, Dr. DeCresce served as Vice President of MetPath, Inc., a division of Corning, Inc., and a predecessor to Quest Diagnostics.
Dr. DeCresce has a Bachelor of Science degree from Boston College, an MD from Columbia University College of Physicians and Surgeons and a Master of Public Health and an MBA from Columbia University.